Core Viewpoint - Wantong Development (600246.SH) has announced a draft for a restricted stock incentive plan for 2025, proposing to grant 94.5206 million shares, which represents 5% of the company's total share capital as of the announcement date [1] Summary by Sections - **Incentive Plan Details** - The number of restricted shares to be granted is 94.5206 million [1] - The grant price is set at 6.25 yuan per share [1] - The effective period of the incentive plan lasts from the date of the first grant of restricted shares until all shares are either released from restrictions or repurchased, with a maximum duration of 60 months [1]

Core Viewpoint - The company, Fantuo Digital Innovation (301313.SZ), has announced a restricted stock incentive plan for 2025, aiming to motivate its employees through stock ownership [1] Group 1: Incentive Plan Details - The company plans to grant a total of 2.7 million restricted shares to 85 incentive recipients, with an initial grant of 2.2 million shares [1] - The grant price for both the initial and reserved restricted shares is set at 14.97 yuan per share [1] - The effective period of the incentive plan will last from the date of the first grant until all granted shares are vested or become invalid, with a maximum duration of 60 months [1]

Core Viewpoint - The company West Gate (605155.SH) has announced a draft for a restricted stock incentive plan for 2025, proposing to grant 3.106 million shares, which accounts for approximately 1.62% of the company's total share capital at the time of the announcement [1] Group 1 - The number of restricted shares to be granted is 3.106 million [1] - The grant price is set at 8.27 yuan per share [1] - The incentive plan will be effective from the completion of the registration of the restricted shares until all shares are released from restrictions or repurchased, with a maximum duration of 36 months [1]

浩瀚深度公告称，公司于2025年10月22日审议通过2025年限制性股票激励计划相关议案。按规定，公司 对激励计划内幕信息知情人在2025年4月23日至10月22日买卖公司股票情况进行查询。核查对象为内幕 信息知情人，他们均填报了登记表，公司向中国结算上海分公司查询并获书面证明。结果显示，自查期 间所有核查对象均无买卖公司股票行为，未发现信息泄露及内幕交易情形。 ...

Core Viewpoint - The article discusses the implementation of a restricted stock incentive plan by the company Mao Ge Ping, aimed at enhancing long-term incentive mechanisms and aligning the interests of shareholders, the company, and management [4]. Group 1: Financial Performance - In the first half of 2025, the company achieved a revenue of 2.59 billion yuan, representing a year-on-year growth of 31.3%, and a net profit attributable to shareholders of 670 million yuan, up 36.1% year-on-year [5]. - For the third quarter of 2025, sales on various platforms showed significant growth: Taobao increased by 25.4%, Douyin by 55.6%, and JD.com by 45.7% [5]. - During the "Double Eleven" sales event, sales continued to perform well, with Taobao, Douyin, and JD.com showing year-on-year growth of 60.5%, 39.8%, and 22.3% respectively [5]. Group 2: Market Position and Product Development - The company has strengthened its high-end beauty positioning, with significant growth in its main product categories and channels [6]. - The product range has expanded from makeup and skincare to include fragrances, with new series such as Guo Yun Ning Xiang and Wen Dao Dong Fang [6]. - The company has successfully entered high-end department stores, including Beijing SKP and Chongqing Xingguang 68, enhancing its offline presence [6]. Group 3: Sales Performance and Rankings - The company achieved notable rankings during the "Double Eleven" event, entering the top 20 in the beauty category on Tmall and ranking first in the domestic makeup category on JD.com [5]. - Several key products have performed exceptionally well, with annual sales exceeding 200,000 units for the Xiaojin Fan powder and over 100,000 units for the Caviar Cushion Foundation and Caviar Mask [5].

Core Viewpoint - The company has completed the repurchase and cancellation of a total of 2,045,200 restricted stocks due to the disqualification of certain incentive recipients, with a total repurchase amount of approximately 29.29 million yuan, which will reduce the total share capital from 2,386,293,256 shares to 2,384,248,056 shares [2][22][36]. Group 1 - The company repurchased and canceled 1,614,450 shares at a price of 15.64 yuan per share and 430,750 shares at a price of 9.38 yuan per share due to the disqualification of 198 incentive recipients [2][22]. - The total repurchase amount for the canceled shares was 29,290,433 yuan, accounting for 0.0857% of the total share capital before cancellation [22][36]. - The repurchase and cancellation procedures have been completed with the Shenzhen branch of China Securities Depository and Clearing Co., Ltd. [2][22]. Group 2 - The company’s stock incentive plan was approved through various board meetings and shareholder meetings, with independent directors expressing their agreement on the related proposals [3][4][5]. - The company has a structured approach to handling disqualified incentive recipients, including those who have left the company or failed to meet performance criteria [24][30]. - The repurchase prices for the restricted stocks were set at 15.64 yuan and 9.38 yuan, reflecting the initial grant prices without adjustments for dividends [26][27]. Group 3 - The company’s total share capital will be reduced to 2,384,248,056 shares following the cancellation of the restricted stocks [22][36]. - The repurchase of restricted stocks is part of the company's ongoing management of its equity incentive plan, ensuring that only eligible recipients retain their shares [24][30]. - The company has confirmed that the repurchase and cancellation will not materially affect its financial status or operational results [37].

Core Points - The company has approved the second unlock period of the 2022 restricted stock incentive plan, allowing 450,088 shares to be released from restrictions on November 18, 2025, which represents 0.0562% of the total share capital [2][15][12] - A total of 279 incentive targets are eligible for the release, but the performance assessment conditions for 100% release were not met, leading to a partial release based on the performance achievement ratio [12][2][15] Summary by Sections Incentive Plan Overview - The 2022 restricted stock incentive plan was approved by the company's board on August 30, 2022, and the first grant of 1,253,500 shares was completed on November 10, 2022 [4][10] - The second unlock period is defined as starting from 36 months after the grant date and lasting until 48 months, with a release ratio of 50% of the granted shares [9][10] Unlock Conditions - The board confirmed that the conditions for the second unlock period have been met, although not all performance targets were achieved [12][14] - The company plans to repurchase and cancel 173,787 shares that did not meet the unlock conditions [12][15] Regulatory Compliance - The board's remuneration and assessment committee, as well as the supervisory board, have verified the eligibility of the incentive targets and the fulfillment of the unlock conditions [12][13][14] - Legal opinions confirm that the release of shares complies with relevant regulations and does not harm the interests of the company or its shareholders [14] Future Actions - The company will handle the necessary procedures for the release of shares and will disclose further information regarding the unlock conditions for the temporarily granted shares [15][16]

Group 1 - The stock price of Enwei Pharmaceutical (301331) closed at 32.37 yuan on November 14, 2025, down 0.77%, with a turnover rate of 2.32% and a trading volume of 23,800 shares, amounting to a transaction value of 77.6852 million yuan [1] - On November 14, the net inflow of main funds was 1.1213 million yuan, indicating a positive short-term attitude from major investors towards the stock [3] - Enwei Pharmaceutical participated in the establishment of a venture capital fund with a contribution of 20 million yuan, accounting for 9.9502% of the total fund size of 201 million yuan, focusing on early and growth-stage companies in the medical and technology sectors [1][3] Group 2 - The company completed the second vesting period of its 2023 restricted stock incentive plan, with 760,200 shares vested, representing 0.7388% of the total share capital [1][3] - The vesting price for the shares was set at 13.48 yuan per share, and the company achieved a performance target with a 17.43% increase in revenue for 2024 compared to 2022, resulting in an 80% vesting ratio [1]

Core Viewpoint - The company has approved the 2025 Restricted Stock Incentive Plan, which includes a list of proposed incentive recipients, following legal and regulatory requirements [1][5]. Disclosure and Verification - The company publicly disclosed the details of the 2025 Restricted Stock Incentive Plan and the list of proposed recipients on the Shanghai Stock Exchange website on November 4, 2025 [1]. - The proposed recipients' names and positions were announced internally via DingTalk from November 4 to November 13, 2025, allowing employees to provide feedback [2]. - No objections were raised by employees regarding the proposed recipients during the public disclosure period [3]. Verification Process - The Board's Compensation and Assessment Committee verified the proposed recipients' qualifications, including their employment contracts and positions within the company [4]. - The committee confirmed that all proposed recipients meet the qualifications set forth by relevant laws and regulations [5]. Compliance with Regulations - The proposed recipients do not fall under any disqualifying conditions as outlined in the management regulations, such as being deemed inappropriate candidates by regulatory bodies within the last 12 months [6]. - The incentive plan includes directors, senior management, key technical personnel, and other essential employees, excluding certain family members of major shareholders and independent directors [7]. - The committee concluded that the proposed recipients' information is accurate and does not contain any misleading elements [7].

青岛海容商用冷链股份有限公司 关于2025年限制性股票激励计划授予结果公告 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或者重大遗漏，并对其内容的真 实性、准确性和完整性承担个别及连带责任。 重要内容提示： 青岛海容商用冷链股份有限公司（以下简称"公司"或"海容冷链"）于2025年11月14日收到中国证券登记 结算有限责任公司上海分公司出具的《证券变更登记证明》和《过户登记确认书》，限制性股票登记日 期为2025年11月13日，根据中国证监会《上市公司股权激励管理办法》、上海证券交易所、中国证券登 记结算有限责任公司上海分公司有关规定，公司完成了2025年限制性股票激励计划的授予登记工作，有 关具体情况公告如下： 证券代码:603187 证券简称:海容冷链 公告编号：2025-058 激励计划授予的限制性股票的解除限售期及各期解除限售时间安排如下表所示： ■ ● 限制性股票登记日：2025年11月13日 ● 限制性股票登记数量：405.4216万股 1、授予日：2025年10月9日。 2、授予数量：405.4216万股。 3、授予人数：149人，包括公司（含全资子公司）核心骨干员工。 4、授 ...